Jessica Tassan
Stock Analyst at Piper Sandler
(0.96)
# 3,767
Out of 4,944 analysts
76
Total ratings
25%
Success rate
-11.22%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Maintains: Overweight | $65 → $69 | $62.99 | +9.54% | 4 | Aug 11, 2025 | |
| HUM Humana | Maintains: Neutral | $288 → $272 | $279.17 | -2.57% | 4 | Jul 31, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $353 → $317 | $270.18 | +17.33% | 8 | Jul 30, 2025 | |
| HNGE Hinge Health | Initiates: Overweight | $41 | $58.37 | -29.76% | 1 | Jun 16, 2025 | |
| OSCR Oscar Health | Maintains: Overweight | $25 → $18 | $15.02 | +19.88% | 5 | Jun 9, 2025 | |
| CTEV Claritev | Upgrades: Overweight | $19 → $44 | $68.28 | -35.56% | 2 | May 29, 2025 | |
| AMWL American Well | Reiterates: Neutral | $10 → $8 | $7.07 | +13.15% | 3 | May 23, 2025 | |
| PINC Premier | Maintains: Neutral | $19 → $24 | $24.31 | -1.28% | 6 | May 21, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $348 → $374 | $286.00 | +30.77% | 4 | May 5, 2025 | |
| CVS CVS Health | Maintains: Overweight | $72 → $74 | $65.86 | +12.36% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $14.87 | +41.22% | 5 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $12 | $7.29 | +64.61% | 6 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $16 | $9.48 | +68.78% | 3 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $8 | $3.19 | +150.78% | 11 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $31 → $33 | $28.37 | +16.32% | 5 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $31.30 | +123.64% | 4 | Aug 2, 2023 |
Doximity
Aug 11, 2025
Maintains: Overweight
Price Target: $65 → $69
Current: $62.99
Upside: +9.54%
Humana
Jul 31, 2025
Maintains: Neutral
Price Target: $288 → $272
Current: $279.17
Upside: -2.57%
UnitedHealth Group
Jul 30, 2025
Maintains: Overweight
Price Target: $353 → $317
Current: $270.18
Upside: +17.33%
Hinge Health
Jun 16, 2025
Initiates: Overweight
Price Target: $41
Current: $58.37
Upside: -29.76%
Oscar Health
Jun 9, 2025
Maintains: Overweight
Price Target: $25 → $18
Current: $15.02
Upside: +19.88%
Claritev
May 29, 2025
Upgrades: Overweight
Price Target: $19 → $44
Current: $68.28
Upside: -35.56%
American Well
May 23, 2025
Reiterates: Neutral
Price Target: $10 → $8
Current: $7.07
Upside: +13.15%
Premier
May 21, 2025
Maintains: Neutral
Price Target: $19 → $24
Current: $24.31
Upside: -1.28%
The Cigna Group
May 5, 2025
Maintains: Overweight
Price Target: $348 → $374
Current: $286.00
Upside: +30.77%
CVS Health
Mar 21, 2025
Maintains: Overweight
Price Target: $72 → $74
Current: $65.86
Upside: +12.36%
Mar 4, 2025
Maintains: Overweight
Price Target: $14 → $21
Current: $14.87
Upside: +41.22%
Feb 27, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $7.29
Upside: +64.61%
Feb 21, 2025
Reiterates: Overweight
Price Target: $17 → $16
Current: $9.48
Upside: +68.78%
Feb 11, 2025
Maintains: Overweight
Price Target: $12 → $8
Current: $3.19
Upside: +150.78%
Jan 29, 2025
Reiterates: Overweight
Price Target: $31 → $33
Current: $28.37
Upside: +16.32%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $31.30
Upside: +123.64%